Hepatocellular Carcinoma After Sustained Virologic Response: Leave No One Behind

J Howell; AJ Thompson

Journal article

Hepatocellular Carcinoma After Sustained Virologic Response: Leave No One Behind

J Howell, AJ Thompson

Gastroenterology | W B SAUNDERS CO-ELSEVIER INC | Published : 2017

DOI: 10.1053/j.gastro.2017.03.025

University of Melbourne Researchers

Jessica Howell Author

Alexander Thompson Author

Grants

Funding Acknowledgements

The authors disclose the following: A. J. Thompson is an Advisory board member for Gilead Sciences, Abbvie, Bristol-Myers Squibb (BMS), and Merck; a speaker for Gilead Sciences, Abbvie, Merck, BMS, Roche Diagnostics; and receives research/grant support (to institution) from Gilead, Abbvie. J. Howell discloses no conflicts.